Skip to main content

Table 1 Participant demographics

From: Impact of APOE ε4 genotype on initial cognitive symptoms differs for Alzheimer’s and Lewy body neuropathology

 

Alzheimer’s pathology (ADP)

Lewy-related and Alzheimer’s (ADP-LRP)

Lewy-related pathology (LRP)

  

N

Mean (Std. Dev) or % of total

N

Mean (Std. Dev) or % of total

N

Mean (Std. Dev) Or % of total

F/χ2

Sig.

Age at first visit, years

1303

76.35 (10.56)

895

73.79 (10.07)

90

73.3 (9.27)

17.9

< 0.0001

Duration from first visit to autopsy, years

1303

4.93 (2.79)

895

5.39 (2.89)

90

4.36 (2.82)

11.29

< 0.0001

Age at death, years

1303

81.28 (10.40)

895

79.08 (10.17)

90

77.67 (8.50)

17.3

< 0.0001

Education, years

1296

15.34 (3.07)

889

15.5 (3.08)

90

15.66 (3.07)

0.95

0.39

Sex % F

1303

45.60%

895

37.40%

90

25%

24.47

< 0.0001

APOE ε4% positive

1303

52.60%

895

61.60%

90

20%

62.98

< 0.0001

Amnestic

1297

80.40%

890

81.10%

89

58.40%

26.5

< 0.0001

Executive/attention

1297

5.86%

890

6.51%

89

11.20%

4.15

0.13

Language

1297

11.50%

890

9.21%

89

20.20%

11

0.004

Visualspatial

1297

2.20%

890

3.10%

89

10.10%

18.7

0.002